Making a Difference
A Life's Journey to Change Things for the Better
Making a Difference
A Life's Journey to Change Things for the Better
A Life's Journey to Change Things for the Better
A Life's Journey to Change Things for the Better
Founded and led the nation’s fastest growing precision medicine company – two years listed on the Inc. 500 and 5000
Founded and led one of the fastest growing technology companies in North America in the health technology field
Two-time finalist for the EY Entrepreneur of the Year Award in Orange County, California
Managing Director of Profound Ventures, a social entrepreneurship fund supporting the growth of models and technologies whose mission is to solve profound societal problems
At 13 years of age following the tragic death of a friend, Brian led the effort to enact the nation’s 1st bicycle helmet law for children.
While in high school, Brian worked with many groups to successfully lobby for over 300 child safety laws enacted across the U.S.
Selected as one of five “Earthly Angels” for his efforts “fighting prejudice, hunger, homelessness, domestic violence and cancer”
Former PTA President who created America’s 1st Green Certified PTA, Avid School Volunteer, Youth Sports Coach, and Lay Clergyman
Former Vice Chair of the Board of Education where he increased public involvement, digital education, six-sigma, and innovation
Serving as President of the Ladera Ranch Education Foundation, the largest non-profit contributor to the local school district, which supports arts, music, and technology programs
The allegations "resulted in the destruction of Proove Biosciences and the smearing of many reputations," Meshkin said.
The U.S. Attorney’s Office said in a court motion last week that it dismissed the case against Brian Javaade Meshkin, 46, “in the interests of justice.” The Ladera Ranch man, founder of Proove Biosciences Inc., was indicted in 2021, along with 8 other defendants on charges of conspiracy and receiving and making illegal payments.
A federal judge in California has dismissed charges against the CEO of embattled genetic testing company Proove Biosciences who along with other individuals had been accused of paying physicians at least $3.5 million in kickbacks.
In a statement published Monday, Proove said, "These false allegations levied against Meshkin and Proove cause
A federal judge in California has dismissed charges against the CEO of embattled genetic testing company Proove Biosciences who along with other individuals had been accused of paying physicians at least $3.5 million in kickbacks.
In a statement published Monday, Proove said, "These false allegations levied against Meshkin and Proove caused tremendous harm, as they have been widely disseminated publicly and in the media. With this dismissal, the defendants are vindicated, and this flawed investigation has been thoroughly discredited."
By Kim Delmonico
The United States government was soundly defeated and forced to ask a Federal Judge to dismiss all charges against an innovative young California company and the clinics it serves.
The judge for the United States District Court in the Central District of California has issued an order granting the United States Government’s
By Kim Delmonico
The United States government was soundly defeated and forced to ask a Federal Judge to dismiss all charges against an innovative young California company and the clinics it serves.
The judge for the United States District Court in the Central District of California has issued an order granting the United States Government’s motion to dismiss all charges in a case involving physicians and other employees from Physical Medical Associates, Ltd., National Spine and Pain Center, LLC, and Proove Biosciences, Inc.
Proove is an Irvine, California-based biosciences company that specializes in the genetic testing of pain patients. According to the company, its “proprietary effective technology” includes “genetic tests and predictive software algorithms in its CLIA-certified, CAP-accredited state-of-the-art laboratory that helped doctors objectively assess pain, predict who would misuse opioids with up to 96.7% accuracy, and provide treatment insights which resulted in 50% pain reduction within 30 days of treatment changes, saving Medicare over $70 million annually.”
The U.S. Department of Justice has quietly dropped criminal charges against the founder and CEO of Proove Biosciences, a genetic testing company based in California that was accused of paying physicians over $3.5 million in illegal kickbacks. A judge dismissed the case against Brian Meshkin and five other defendants last month “in the int
The U.S. Department of Justice has quietly dropped criminal charges against the founder and CEO of Proove Biosciences, a genetic testing company based in California that was accused of paying physicians over $3.5 million in illegal kickbacks. A judge dismissed the case against Brian Meshkin and five other defendants last month “in the interests of justice” after federal prosecutors declined to move forward with the case.
Jason de Bretteville, defense attorney for the lead defendant, Proove CEO Brian Meshkin, said the government attorneys never disclosed specifically why they sought a dismissal, but he speculated it was based on the case’s merits and “emerging issues relating to potential government misconduct.”
Meshkin said the decision to dismiss the case
Jason de Bretteville, defense attorney for the lead defendant, Proove CEO Brian Meshkin, said the government attorneys never disclosed specifically why they sought a dismissal, but he speculated it was based on the case’s merits and “emerging issues relating to potential government misconduct.”
Meshkin said the decision to dismiss the case was vindication for him and his co-defendants.
“There has been so much injustice over the past (six) years that it is wonderful to see truth prevail,” Meshkin wrote in a statement he sent to the Union-Tribune. “Ultimately, the facts spoke for themselves.”
Meshkin called the investigation a “foolish” waste of millions of taxpayer dollars that resulted from “misinformation spread by a handful of disgruntled ex-employees and contractors, spread by the media, and blindly adopted by some in the Southern District of California office of the U.S. Attorney and the FBI.”
A federal judge in California has dismissed charges against the CEO of embattled genetic testing company Proove Biosciences.
“There has been so much injustice over the past 6 years that it is wonderful to see truth prevail. I am excited to have the opportunity to set the record straight and to move forward from here with my head held high,”
By Sherry Hseih, Healthcare Editor
By Mary Corey
By Vita Reed
By Jeniece Pettitt
By Dina Gusovsky